No Data
No Data
No Data
No Data
No Data
FYBR, BCRX and SABR Are Among After Hour Movers
Seeking AlphaApr 18 16:56 ET
Express News | BioCryst Pharmaceuticals Announced That The Brazilian Health Regulatory Agency Has Granted Approval For Oral, Once-daily ORLADEYO (Berotralstat) For The Prophylaxis Of Hereditary Angioedema (Hae) Attacks In Adults And Pediatric Patients 12 Years
Moomoo 24/7Apr 17 04:36 ET
Express News | BioCryst Announces Approval of Orladeyo® (Berotralstat) by the Brazilian Health Regulatory Agency
Moomoo 24/7Apr 17 04:30 ET
Express News | Needham Reiterates Buy on BioCryst Pharma, Maintains $12 Price Target
Moomoo 24/7Apr 10 07:10 ET
BioCryst Pharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/10/2024 147.42% Needham → $12 Reiterates Buy → Buy 01/08/2024 147.42% Needham → $12 Reiterates Buy → Bu
BenzingaApr 10 07:08 ET
Why Investors Shouldn't Be Surprised By BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) Low P/S
With a price-to-sales (or "P/S") ratio of 2.9x BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) may be sending very bullish signals at the moment, given that almost half of all the Biotechs companies in t
Simply Wall StApr 8 13:31 ET
Kevin Matte : finally i bought it today ^^
TrytosaveabitOP Kevin Matte: GL and big profits to ya! I’m still waiting a bit to see if seems to be at bottom!
J L 7 2 : 今天为啥股市没开啊
JESSE JAMES8832 : presidents day
TrytosaveabitOP J L 7 2: Presidents Day in the United States!
J L 7 2 : 哦总统 生日快乐福星高照
Kevin Matte : good call on this one ! will watch ^^
No Data
No Data